5-Amino-1MQ: A 'Fat-Loss Peptide' That Isn't a Peptide — or Proven

Scroll any "peptide" vendor's fat-loss section and you'll find 5-Amino-1MQ sitting comfortably among the injectable peptides, sold with the same promise: lose fat, boost your NAD+, rev up your metabolism. As with MK-677, there's a catch the listing rarely makes clear — 5-Amino-1MQ isn't a peptide at all, and its evidence is thinner than the confident marketing implies. Here's the honest version.

What is 5-Amino-1MQ?

5-Amino-1MQ (5-amino-1-methylquinolinium) is an orally active small molecule, not a peptide. It works by blocking an enzyme called NNMT (nicotinamide N-methyltransferase), which is more active in the fat tissue of obese people and animals. The theory is neat: NNMT uses up nicotinamide and consumes "methyl groups", so blocking it should raise cellular NAD+ (the energy-and-repair molecule we cover in our NAD explainer) and push fat cells toward burning rather than storing ².

It's a genuinely interesting metabolic target — which is exactly why it's being researched. But "interesting target" and "proven, safe fat-loss pill" are very different things, and the distance between them is the whole story here.

What does the evidence show?

This one is unusually clear-cut, because the evidence sits almost entirely in one species.

In mice, the results are striking. When obese mice were given an NNMT inhibitor, they lost body weight and fat mass, with smaller fat cells and lower cholesterol — and, notably, without eating less and without obvious side effects in those studies ¹. Later work reinforced that blocking NNMT improves obesity-related metabolic problems in animal models ³. For a metabolism researcher, that's a genuinely promising signal.

In humans, there's essentially nothing. And this is the crux: there are no published human clinical trials showing that 5-Amino-1MQ is safe or that it causes weight loss in people. The entire consumer pitch rests on mouse data plus a plausible mechanism. We've seen this movie before — including with AOD-9604, where encouraging mouse fat-loss results simply didn't carry over to humans.

The approval and sourcing problem

5-Amino-1MQ is not an approved medicine, and what's sold online is an unregulated "research" compound — unknown purity, dose and manufacturing, with the same grey-market problems we describe across the peptide category (even though, strictly, this one isn't a peptide). Taking an oral research chemical daily, at a guessed dose, on the strength of mouse data, is a very different proposition from a tested medicine.

What we see at the clinic

5-Amino-1MQ comes up with people who want the fat-loss results of the new metabolic drugs but are looking for a "natural-feeling" pill instead of an injection. We're honest on two fronts: first, it isn't a peptide, so anyone buying it as one should at least know what it is; second, and more important, the impressive data are in mice, and there are no human trials to lean on. Against the GLP-1 medications that have genuinely transformed weight loss on the strength of large human trials, an unproven mouse-stage research chemical is a poor bet. Durable fat loss still comes from proven approaches and, where appropriate, properly supervised medication — not an unregulated pill chasing a promising mechanism.

Common questions

Is 5-Amino-1MQ a peptide? No. It's an orally active small molecule that inhibits the NNMT enzyme. It's sold alongside peptides, but chemically it isn't one.

Does it cause weight loss? In obese mice, yes — meaningful fat and weight loss ¹. In humans, there are no published trials showing it works or is safe.

Does it really boost NAD+? Blocking NNMT raises NAD+ in cells and animal models ². Whether that produces the promised human benefits hasn't been tested in proper trials.

Is it safe? Unknown in humans — no clinical safety data, and what's sold is unregulated. Mouse studies not showing side effects is not the same as proven human safety.

Key takeaway

5-Amino-1MQ is a clever metabolic idea wrapped in misleading packaging: it's marketed as a fat-loss peptide, but it's a small molecule, and its striking weight-loss data are mouse-only, with no human trials and no approval. The NNMT/NAD+ mechanism is genuinely interesting research — but interesting in mice is not proven in people, as the fat-loss peptide graveyard keeps reminding us. Know what you're taking, and don't mistake a promising animal result for a proven human treatment.